Implanet S.A. (FRA:IM11)

Market Cap	27.63M
Revenue (ttm)	11.10M
Net Income (ttm)	-4.81M
Shares Out	n/a
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	4,680
Open	0.1855
Previous Close	0.2040
Day's Range	0.1855 - 0.1855
52-Week Range	0.0768 - 0.4280
Beta	n/a
RSI	38.54
Earnings Date	Mar 4, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S....

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2006
• Employees: 46
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IM11

Financial Performance

In 2024, Implanet's revenue was 9.41 million, an increase of 26.31% compared to the previous year's 7.45 million. Losses were -4.37 million, -34.60% less than in 2023.